| Product Code: ETC6738012 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of biosurgery products to China in 2024 show a notable shift towards high concentration, with the USA, Denmark, UK, Netherlands, and Germany being the top exporting countries. The Herfindahl-Hirschman Index (HHI) indicates a significant increase in market concentration compared to 2023. Despite a negative Compound Annual Growth Rate (CAGR) of -0.42% from 2020 to 2024, the growth rate from 2023 to 2024 experienced a steeper decline at -6.68%. This suggests a challenging market environment for biosurgery imports in China, possibly influenced by various factors impacting the industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Biosurgery Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Biosurgery Market Revenues & Volume, 2021 & 2031F |
3.3 China Biosurgery Market - Industry Life Cycle |
3.4 China Biosurgery Market - Porter's Five Forces |
3.5 China Biosurgery Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 China Biosurgery Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 China Biosurgery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring surgical interventions |
4.2.2 Growing demand for minimally invasive surgeries |
4.2.3 Technological advancements in biosurgery products |
4.2.4 Rising healthcare expenditure in China |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for product approval |
4.3.2 Limited awareness about biosurgery products among healthcare professionals |
4.3.3 High cost associated with biosurgery procedures |
4.3.4 Lack of reimbursement policies for certain biosurgery products |
5 China Biosurgery Market Trends |
6 China Biosurgery Market, By Types |
6.1 China Biosurgery Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 China Biosurgery Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 China Biosurgery Market Revenues & Volume, By Bone-Graft Substitutes, 2021- 2031F |
6.1.4 China Biosurgery Market Revenues & Volume, By Soft-Tissue Attachments, 2021- 2031F |
6.1.5 China Biosurgery Market Revenues & Volume, By Haemostatic Agents, 2021- 2031F |
6.1.6 China Biosurgery Market Revenues & Volume, By Surgical Sealants and Adhesives, 2021- 2031F |
6.1.7 China Biosurgery Market Revenues & Volume, By Adhesion Barriers and Staple-Line Reinforcement Agents, 2021- 2031F |
6.2 China Biosurgery Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Biosurgery Market Revenues & Volume, By General Surgery, 2021- 2031F |
6.2.3 China Biosurgery Market Revenues & Volume, By Cardiovascular Surgery, 2021- 2031F |
6.2.4 China Biosurgery Market Revenues & Volume, By Orthopaedic Surgery, 2021- 2031F |
6.2.5 China Biosurgery Market Revenues & Volume, By Neurological Surgery, 2021- 2031F |
6.2.6 China Biosurgery Market Revenues & Volume, By Reconstructive Surgery, 2021- 2031F |
6.2.7 China Biosurgery Market Revenues & Volume, By Gynaecological Surgery, 2021- 2031F |
6.2.8 China Biosurgery Market Revenues & Volume, By Urological Surgery, 2021- 2031F |
6.2.9 China Biosurgery Market Revenues & Volume, By Urological Surgery, 2021- 2031F |
7 China Biosurgery Market Import-Export Trade Statistics |
7.1 China Biosurgery Market Export to Major Countries |
7.2 China Biosurgery Market Imports from Major Countries |
8 China Biosurgery Market Key Performance Indicators |
8.1 Adoption rate of new biosurgery technologies in Chinese hospitals |
8.2 Number of clinical trials and research studies on biosurgery products in China |
8.3 Percentage of healthcare facilities offering biosurgery procedures |
8.4 Rate of complications or adverse events related to biosurgery procedures |
8.5 Patient satisfaction and outcomes after biosurgery interventions |
9 China Biosurgery Market - Opportunity Assessment |
9.1 China Biosurgery Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 China Biosurgery Market Opportunity Assessment, By Application, 2021 & 2031F |
10 China Biosurgery Market - Competitive Landscape |
10.1 China Biosurgery Market Revenue Share, By Companies, 2024 |
10.2 China Biosurgery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here